001630 — Chongkundang Holdings Share Price
- KR₩278bn
- KR₩933bn
- KR₩880bn
- 55
- 81
- 63
- 80
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 28.99 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | -45.46% | ||
Dividend Yield (f) | 2.39% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.48 | ||
Price to Tang. Book | 0.5 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.29 | ||
EV to EBITDA | 14.66 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 1.89% | ||
Return on Equity | 8.55% | ||
Operating Margin | 1.9% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 720,644.04 | 858,118.78 | 925,975.08 | 908,962.76 | 879,780.77 | 924,000 | 970,000 | 10.62% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +59.41 | +78.68 | -80.75 | -93.62 | +5786.54 | -86.41 | +37.76 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
CHONGKUNDANG HOLDINGS CORP., formerly Chong Kun Dang Pharmaceutical Corp., is a Korea-based company engaged in the investment business. Through its subsidiary, the Company provides pharmaceuticals, including remedies for high blood pressure and high cholesterol, immunosuppressive drugs, antitumor agents, antibiotics, remedies for erectile dysfunction and remedies for obesity. It also produces antitumor agents, antibiotics, digestives, circulation agents, respiratory agents, remedies for endocrine diseases, remedies for skin diseases, functional cosmetics and others, as well as pharmaceutical ingredients. On November 2, 2013, the Company divested its pharmaceutical business into a newly established wholly owned subsidiary. After the divestiture, the Company engages in the investment and holding business.
Directors
- Jang Han Lee CHM (62)
- Jang Won Choi CEO
- Seong Gi Kim SMD (58)
- Seung Ho Ha MDR (59)
- Chang Gyu Kim MDR (57)
- Yun Ha Lee MDR (54)
- Hong Sun Park MDR (56)
- Hyo Muk Cho OTH (55)
- Su Yeong Choi OTH (46)
- Do Seon Gwon OTH (51)
- Seong Wuk Han OTH (42)
- Sun Gang Hong OTH (52)
- Gwang Hui Jung OTH (52)
- Gwang Jong Kim OTH (53)
- Jin Kim OTH (49)
- Jong Bin Kim OTH (48)
- Seong Nam Kim OTH (59)
- Yun Han Lee OTH (54)
- Yil Seop Song OTH (52)
- Tae Yeong Kim DRC (54)
- Jae Hun Yoon DRC (51)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 10th, 1956
- Public Since
- June 30th, 1976
- No. of Shareholders
- 12,551
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 4,760,558
- Address
- Chongkundang Building, SEOUL, 03742
- Web
- https://www.ckd-holdings.com/
- Phone
- +82 263730600
- Auditors
- Ernst & Young Han Young
Upcoming Events for 001630
Q4 2024 Chongkundang Holdings Corp Earnings Release
Chongkundang Holdings Corp Annual Shareholders Meeting
Similar to 001630
Binggrae Co
Korea Exchange - KSE
Bolak Co
Korea Exchange - KSE
Choheung
Korea Exchange - KSE
CJ CheilJedang
Korea Exchange - KSE
Cj
Korea Exchange - KSE
FAQ
As of Today at 19:57 UTC, shares in Chongkundang Holdings are trading at KR₩58,500. This share price information is delayed by 15 minutes.
Shares in Chongkundang Holdings last closed at KR₩58,500 and the price had moved by +8.52% over the past 365 days. In terms of relative price strength the Chongkundang Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -3.72% over the past year.
The overall consensus recommendation for Chongkundang Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Chongkundang Holdings dividend yield is 2.39% based on the trailing twelve month period.
Last year, Chongkundang Holdings paid a total dividend of KR₩1,400, and it currently has a trailing dividend yield of 2.39%. We do not have any data on when Chongkundang Holdings is to next pay dividends.
We do not have data on when Chongkundang Holdings is to next pay dividends. The historic dividend yield on Chongkundang Holdings shares is currently 2.39%.
To buy shares in Chongkundang Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩58,500, shares in Chongkundang Holdings had a market capitalisation of KR₩278bn.
Here are the trading details for Chongkundang Holdings:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 001630
Based on an overall assessment of its quality, value and momentum Chongkundang Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Chongkundang Holdings is KR₩70,000. That is 19.66% above the last closing price of KR₩58,500.
Analysts covering Chongkundang Holdings currently have a consensus Earnings Per Share (EPS) forecast of KR₩1,557 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chongkundang Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -10.43%.
As of the last closing price of KR₩58,500, shares in Chongkundang Holdings were trading +0.58% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Chongkundang Holdings PE ratio based on its reported earnings over the past 12 months is 28.99. The shares last closed at KR₩58,500.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Chongkundang Holdings' management team is headed by:
- Jang Han Lee - CHM
- Jang Won Choi - CEO
- Seong Gi Kim - SMD
- Seung Ho Ha - MDR
- Chang Gyu Kim - MDR
- Yun Ha Lee - MDR
- Hong Sun Park - MDR
- Hyo Muk Cho - OTH
- Su Yeong Choi - OTH
- Do Seon Gwon - OTH
- Seong Wuk Han - OTH
- Sun Gang Hong - OTH
- Gwang Hui Jung - OTH
- Gwang Jong Kim - OTH
- Jin Kim - OTH
- Jong Bin Kim - OTH
- Seong Nam Kim - OTH
- Yun Han Lee - OTH
- Yil Seop Song - OTH
- Tae Yeong Kim - DRC
- Jae Hun Yoon - DRC